Recent Publications

  • Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J; Liverpool and Manchester Neurodevelopment Group. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology. 2015 Jan 27;84(4):382-90. doi: 10.1212/WNL.0000000000001182.
  • Dixon PA, Kirkham JJ, Marson AG, Pearson MG. National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK. BMJ Open. 2015 Mar 31;5(3):e007325. doi: 10.1136/bmjopen-2014-007325.
  • Jacoby A, Sudell M, Tudur Smith C, Crossley J, Marson AG, Baker GA; SANAD Study Group. Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial. Epilepsia. 2015 Mar;56(3):460-72. doi: 10.1111/epi.12913.
  • Keller SS, Richardson MP, O'Muircheartaigh J, Schoene-Bake JC, Elger C, Weber B. Morphometric MRI alterations and postoperative seizure control in refractory temporal lobe epilepsy. Hum Brain Mapp. 2015 May;36(5):1637-47. doi: 10.1002/hbm.22722.
  • Keller SS, Richardson MP, Schoene-Bake JC, O'Muircheartaigh J, Elkommos S, Kreilkamp B, Goh YY, Marson AG, Elger C, Weber B. Thalamotemporal alteration and postoperative seizures in temporal lobe epilepsy. Ann Neurol. 2015 May;77(5):760-74. doi: 10.1002/ana.24376.
  • Mawer G, Bromley R, Baker GA, Meador KJ, Clayton-Smith J. Fine-tuning risk assessment with antiepileptic drug use in pregnancy. Neurology. 2015 Oct 13;85(15):1354. doi: 10.1212/WNL.0000000000002050.
  • Mirza N, Appleton R, Burn S, Carr D, Crooks D, du Plessis D, Duncan R, Farah JO, Josan V, Miyajima F, Mohanraj R, Shukralla A, Sills GJ, Marson AG, Pirmohamed M. Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Hum Mol Genet. 2015 Aug 1;24(15):4306-16. doi: 10.1093/hmg/ddv163.
  • Plumpton CO, Brown I, Reuber M, Marson AG, Hughes DA. Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence. Epilepsy Behav. 2015 Apr;45:180-6. doi: 10.1016/j.yebeh.2015.01.035.
  • Walker LE, Mirza N, Yip VL, Marson AG, Pirmohamed M. Personalized medicine approaches in epilepsy. J Intern Med. 2015 Feb;277(2):218-34. doi: 10.1111/joim.12322.
  • Wilson SJ, Baxendale S, Barr W, Hamed S, Langfitt J, Samson S, Watanabe M, Baker GA, Helmstaedter C, Hermann BP, Smith ML. Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia. 2015 May;56(5):674-81. doi: 10.1111/epi.12962. 

See all publications

  • Adab N, Tudur Smith C, Vinten J, Williamson PR, Winterbottom JB, McKay AJ, Bromley R. WITHDRAWN: Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev. 2015 Dec 17;12:CD004848. doi: 10.1002/14651858.CD004848.pub2.
  • Baker GA, Bromley RL, Briggs M, Cheyne CP, Cohen MJ, García-Fiñana M, Gummery A, Kneen R, Loring DW, Mawer G, Meador KJ, Shallcross R, Clayton-Smith J; Liverpool and Manchester Neurodevelopment Group. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology. 2015 Jan 27;84(4):382-90. doi: 10.1212/WNL.0000000000001182.
  • Bonilha L, Keller SS. Quantitative MRI in refractory temporal lobe epilepsy: relationship with surgical outcomes. Quant Imaging Med Surg. 2015 Apr;5(2):204-24. doi: 10.3978/j.issn.2223-4292.2015.01.01.
  • Carmichael K, Nolan SJ, Weston J, Tudur Smith C, Marson AG. Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria. Epilepsy Res. 2015 Aug;114:106-13. doi: 10.1016/j.eplepsyres.2015.04.019. 
  • Dixon PA, Kirkham JJ, Marson AG, Pearson MG. National Audit of Seizure management in Hospitals (NASH): results of the national audit of adult epilepsy in the UK. BMJ Open. 2015 Mar 31;5(3):e007325. doi: 10.1136/bmjopen-2014-007325.
  • Donegan S, Dixon P, Hemming K, Tudur-Smith C, Marson A. A systematic review of placebo-controlled trials of topiramate: How useful is a multiple-indications review for evaluating the adverse events of an antiepileptic drug? Epilepsia. 2015 Dec;56(12):1910-20. doi: 10.1111/epi.13209.
  • Elkommos S, Richardson MP, Schoene-Bake JC, Marson A, Elger C, Weber B, Keller SS. Presurgical entorhinal cortex volume and postoperative seizure outcome in temporal lobe epilepsy. Lancet. 2015 Feb 26;385 Suppl 1:S34. doi: 10.1016/S0140-6736(15)60349-X.
  • Epilepsy Phenome/Genome Project Epi4K Consortium. Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy. Ann Neurol. 2015 Aug;78(2):323-8. doi: 10.1002/ana.24457.
  • Hutchings F, Han CE, Keller SS, Weber B, Taylor PN, Kaiser M. Predicting Surgery Targets in Temporal Lobe Epilepsy through Structural Connectome Based Simulations. PLoS Comput Biol. 2015 Dec 10;11(12):e1004642. doi: 10.1371/journal.pcbi.1004642.
  • Jackson CF, Makin SM, Marson AG, Kerr M. Non-pharmacological interventions for people with epilepsy and intellectual disabilities. Cochrane Database Syst Rev. 2015 Sep 10;9:CD005502. doi: 10.1002/14651858.CD005502.pub3.
  • Jackson CF, Makin SM, Marson AG, Kerr M. Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev. 2015 Sep 3;9:CD005399. doi: 10.1002/14651858.CD005399.pub3.
  • Jackson CF, Makin SM, Baker GA. Neuropsychological and psychological interventions for people with newly diagnosed epilepsy. Cochrane Database Syst Rev. 2015 Jul 22;7:CD011311. doi: 10.1002/14651858.CD011311.pub2.
  • Jacoby A, Sudell M, Tudur Smith C, Crossley J, Marson AG, Baker GA; SANAD Study Group. Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trial. Epilepsia. 2015 Mar;56(3):460-72. doi: 10.1111/epi.12913.
  • Jacoby A, Snape D, Lane S, Baker GA. Self-reported anxiety and sleep problems in people with epilepsy and their association with quality of life. Epilepsy Behav. 2015 Feb;43:149-58. doi: 10.1016/j.yebeh.2014.09.071.
  • Jacoby A. Thirty years of psychosocial research in epilepsy: personal reflections of a social scientist. Epilepsy Behav. 2015 Mar;44:245-9. doi: 10.1016/j.yebeh.2014.12.008.
  • Keller SS, Richardson MP, O'Muircheartaigh J, Schoene-Bake JC, Elger C, Weber B. Morphometric MRI alterations and postoperative seizure control in refractory temporal lobe epilepsy. Hum Brain Mapp. 2015 May;36(5):1637-47. doi: 10.1002/hbm.22722.
  • Keller SS, Richardson MP, Schoene-Bake JC, O'Muircheartaigh J, Elkommos S, Kreilkamp B, Goh YY, Marson AG, Elger C, Weber B. Thalamotemporal alteration and postoperative seizures in temporal lobe epilepsy. Ann Neurol. 2015 May;77(5):760-74. doi: 10.1002/ana.24376.
  • Magill N, Ridsdale L, Goldstein LH, McCrone P, Morgan M, Noble AJ, Baker G, Richardson M, Taylor S, Landau S. Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial. Trials. 2015 Jun 12;16:269. doi: 10.1186/s13063-015-0788-9.
  • Mawer G, Bromley R, Baker GA, Meador KJ, Clayton-Smith J. Fine-tuning risk assessment with antiepileptic drug use in pregnancy. Neurology. 2015 Oct 13;85(15):1354. doi: 10.1212/WNL.0000000000002050.
  • Milburn-McNulty P, Powell G, Sills GJ, Marson AG. Sulthiame add-on therapy for epilepsy. Cochrane Database Syst Rev. 2015 Oct 28;10:CD009472. doi: 10.1002/14651858.CD009472.pub3.
  • Mirza N, Appleton R, Burn S, Carr D, Crooks D, du Plessis D, Duncan R, Farah JO, Josan V, Miyajima F, Mohanraj R, Shukralla A, Sills GJ, Marson AG, Pirmohamed M. Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality. Hum Mol Genet. 2015 Aug 1;24(15):4306-16. doi: 10.1093/hmg/ddv163.
  • Munsell BC, Wee CY, Keller SS, Weber B, Elger C, da Silva LA, Nesland T, Styner M, Shen D, Bonilha L. Evaluation of machine learning algorithms for treatment outcome prediction in patients with epilepsy based on structural connectome data. Neuroimage. 2015 Sep;118:219-30. doi: 10.1016/j.neuroimage.2015.06.008.
  • Noble AJ, Marson AG, Tudur-Smith C, Morgan M, Hughes DA, Goodacre S, Ridsdale L. 'Seizure First Aid Training' for people with epilepsy who attend emergency departments, and their family and friends: study protocol for intervention development and a pilot randomised controlled trial. BMJ Open. 2015 Jul 24;5(7):e009040. doi: 10.1136/bmjopen-2015-009040.
  • Noble AJ. Unplanned hospital use by people with epilepsy: A lever by which to bring about increased self-management support? Epilepsy Behav. 2015 Oct;51:57-9. doi: 10.1016/j.yebeh.2015.07.018.
  • Nolan SJ, Marson AG, Weston J, Tudur Smith C. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2015 Aug 14;8:CD001911. doi: 10.1002/14651858.CD001911.pub2.
  • Nolan SJ, Marson AG, Weston J, Tudur Smith C. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2015 Jul 23;7:CD001904. doi: 10.1002/14651858.CD001904.pub2.
  • O'Muircheartaigh J, Keller SS, Barker GJ, Richardson MP. White Matter Connectivity of the Thalamus Delineates the Functional Architecture of Competing Thalamocortical Systems. Cereb Cortex. 2015 Nov;25(11):4477-89. doi: 10.1093/cercor/bhv063.
  • Panebianco M, Rigby A, Weston J, Marson AG. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev. 2015 Apr 3;4:CD002896. doi: 10.1002/14651858.CD002896.pub2.
  • Plumpton CO, Yip VL, Alfirevic A, Marson AG, Pirmohamed M, Hughes DA. Cost-effectiveness of screening for HLA-A*31:01 prior to initiation of carbamazepine in epilepsy. Epilepsia. 2015 Apr;56(4):556-63.
  • Plumpton CO, Brown I, Reuber M, Marson AG, Hughes DA. Economic evaluation of a behavior-modifying intervention to enhance antiepileptic drug adherence. Epilepsy Behav. 2015 Apr;45:180-6. doi: 10.1016/j.yebeh.2015.01.035.
  • Pohlmann-Eden B, Aldenkamp A, Baker GA, Brandt C, Cendes F, Coras R, Crocker CE, Helmstaedter C, Jones-Gotman M, Kanner AM, Mazarati A, Mula M, Smith ML, Omisade A, Tellez-Zenteno J, Hermann BP. The relevance of neuropsychiatric symptoms and cognitive problems in new-onset epilepsy - Current knowledge and understanding. Epilepsy Behav. 2015 Oct;51:199-209. doi: 10.1016/j.yebeh.2015.07.005.
  • Powell G, Holmes EA, Plumpton CO, Ring A, Baker GA, Jacoby A, Pirmohamed M, Marson AG, Hughes DA. Pharmacogenetic testing prior to carbamazepine treatment of epilepsy: patients' and physicians' preferences for testing and service delivery. Br J Clin Pharmacol. 2015 Nov;80(5):1149-59. doi: 10.1111/bcp.12715.
  • Sonecha S, Noble AJ, Morgan M, Ridsdale L. Perceptions and experiences of epilepsy among patients from black ethnic groups in South London. Prim Health Care Res Dev. 2015 Sep;16(5):450-60. doi: 10.1017/S1463423614000437.
  • Strozzi I, Nolan SJ, Sperling MR, Wingerchuk DM, Sirven J. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2015 Feb 11;2:CD001902. doi: 10.1002/14651858.CD001902.pub2.
  • Walker LE, Mirza N, Yip VL, Marson AG, Pirmohamed M. Personalized medicine approaches in epilepsy. J Intern Med. 2015 Feb;277(2):218-34. doi: 10.1111/joim.12322.
  • Warburton A, Miyajima F, Shazadi K, Crossley J, Johnson MR, Marson AG, Baker GA, Quinn JP, Sills GJ. NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy. Epilepsy Behav. 2015 Dec 17;54:117-127. doi: 10.1016/j.yebeh.2015.11.013.
  • West S, Nolan SJ, Cotton J, Gandhi S, Weston J, Sudan A, Ramirez R, Newton R. Surgery for epilepsy. Cochrane Database Syst Rev. 2015 Jul 1;7:CD010541. doi: 10.1002/14651858.CD010541.pub2.
  • Weston J, Shukralla A, McKay AJ, Marson AG. Lacosamide add-on therapy for partial epilepsy. Cochrane Database Syst Rev. 2015 Jun 16;6:CD008841. doi: 10.1002/14651858.CD008841.pub2.
  • Weston J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev. 2015 Mar 4;3:CD007286. doi: 10.1002/14651858.CD007286.pub3.
  • Wieshmann UC, Milinis K, Paniker J, Das K, Jenkinson MD, Brodbelt A, Crooks D, Keller SS. The role of the corpus callosum in seizure spread: MRI lesion mapping in oligodendrogliomas. Epilepsy Res. 2015 Jan;109:126-33. doi: 10.1016/j.eplepsyres.2014.10.023.
  • Wilson S; Task Force members. In response: Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia. 2015 Aug;56(8):1316-7. doi: 10.1111/epi.13055.
  • Wilson SJ, Baxendale S, Barr W, Hamed S, Langfitt J, Samson S, Watanabe M, Baker GA, Helmstaedter C, Hermann BP, Smith ML. Indications and expectations for neuropsychological assessment in routine epilepsy care: Report of the ILAE Neuropsychology Task Force, Diagnostic Methods Commission, 2013-2017. Epilepsia. 2015 May;56(5):674-81. doi: 10.1111/epi.12962.